BioQuest

BioQuest EBITDA Margin

The EBITDA Margin of BioQuest (BQST) as of Nov 3, 2026 is -469.33 %. In the previous year, EBITDA Margin was -574.04 % — a change of -18.24% (higher).

EBITDA Margin

-469.33 %

YoY

-18.24%

Last updated:

EBITDA Margin of BioQuest is 2026 -469.33 % . EBITDA Margin of BioQuest was 2025 -574.04 % . It decreases by -18.24% higher compared to the previous year.

The BioQuest EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2025
-574.04 USD
Jan 1, 2026
-469.33 USD
The BioQuest EBITDA Margin history
YEAREBITDA MarginYoY
-469.33 %-18.24%
-574.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioQuest Stock analysis

What does BioQuest do? BioQuest Corp. makes money through acquiring companies in the green energy sector, such as Progressus Clean Technologies, Inc., which focuses on hydrogen generation and separation technologies. The company executes letters of intent to acquire private firms like Progressus, which owns intellectual property for extracting hydrogen from gas streams. Progressus has not generated any revenue, but BioQuest aims to monetize its acquisitions by developing and commercializing these technologies. BioQuest targets investors seeking exposure to emerging green energy technologies through its acquisition strategy. BioQuest Corp. operates in the green energy sector, specifically targeting venture-stage companies with innovative technologies. The firm's primary product is the acquisition of companies like Progressus, which holds intellectual property for hydrogen extraction. BioQuest does not generate revenue from its own operations but relies on the future revenue potential of acquired companies. The company's business model centers on identifying and acquiring early-stage green technology firms with scalable intellectual property. The company's focus on acquiring private companies such as Progressus Clean Technologies, Inc., which is developing hydrogen generation and separation technologies, positions BioQuest to capitalize on the growing demand for clean energy solutions. Progressus's intellectual property for extracting hydrogen from gas streams represents a key asset that BioQuest aims to leverage. BioQuest Corp. targets investors interested in the green energy sector through its strategic acquisitions, expecting future revenue from the commercialization of these technologies. BioQuest is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioQuest stock

EBITDA Margin of BioQuest is -469.33 % in 2026.

EBITDA Margin of BioQuest changed from -574.04 % to -469.33 %, representing a -18.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin BioQuest since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's BioQuest with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — BioQuest

All Key Metrics — BioQuest